Focus: OrthAlign develops inertial navigation systems for joint replacement surgery, operating in the musculoskeletal device space as a specialized medical technology company. The company is headquartered in Irvine, CA and focuses on surgical guidance solutions rather than traditional pharmaceutical drug development.
Profile data last refreshed 3h ago · AI intelligence enriched 3w ago
Stable — net +2 jobs in 30d
2 added, 0 removed. Backfill posture.
OrthAlign is a high-risk, high-upside play for technologists or commercial operators willing to bet on a surgical device company in its scaling phase.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for OrthAlign
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from OrthAlign's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo